StockMacro
Menu

Scholar Rock

$48.13 -6.6% in 6 monthsMarket cap $5.9B

SRRK on XNAS, Health Care, Scholar Rock Holding Corporation, job postings

Measures activity, not value. Not investment advice.

Short interest is 19% of shares and rising, while insiders bought $12M of stock.

  • BadNet loss $413.6M over 12 months on revenue of $570K

Written by AI from the data on this page, 21 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

Industry
Biological products, (no diagnostic substances) (Health Care)
Employees
289
Website
scholarrock.com
Listed
Nasdaq, US
Last results
10 Nov 2026
Next results
expected around 11 Jan 2027 (an estimate: a year ago it reported on 12 Jan 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $570K, net loss $107.2M.
Quarter to 31 Dec 2021: revenue $4.0M, net income -$35.9MQuarter to 31 Dec 2021: revenue $4.0M, net income -$35.9MQuarter to 31 Mar 2022: revenue $33.2M, net income -$8.0MQuarter to 31 Mar 2022: revenue $33.2M, net income -$8.0MQuarter to 30 Jun 2022: revenue $0, net income -$44.0MQuarter to 30 Jun 2022: revenue $0, net income -$44.0MQuarter to 30 Sep 2022: revenue $0, net income -$43.3MQuarter to 30 Sep 2022: revenue $0, net income -$43.3MQuarter to 31 Dec 2022: revenue $0, net income -$39.3MQuarter to 31 Dec 2022: revenue $0, net income -$39.3MQuarter to 31 Mar 2023: revenue –, net income -$39.4MQuarter to 30 Jun 2023: revenue –, net income -$37.9MQuarter to 30 Sep 2023: revenue –, net income -$42.4MQuarter to 31 Dec 2023: revenue –, net income -$46.1MQuarter to 31 Mar 2024: revenue –, net income -$56.9MQuarter to 30 Jun 2024: revenue –, net income -$58.5MQuarter to 30 Sep 2024: revenue –, net income -$64.5MQuarter to 31 Dec 2024: revenue –, net income -$66.5MQuarter to 31 Mar 2025: revenue –, net income -$74.7MQuarter to 30 Jun 2025: revenue –, net income -$110.0MQuarter to 30 Sep 2025: revenue $0, net income -$102.2MQuarter to 30 Sep 2025: revenue $0, net income -$102.2MQuarter to 31 Dec 2025: revenue $0, net income -$91.0MQuarter to 31 Dec 2025: revenue $0, net income -$91.0MQuarter to 31 Mar 2026: revenue $0, net income -$105.5MQuarter to 31 Mar 2026: revenue $0, net income -$105.5MQuarter to 30 Jun 2026: revenue $0, net income -$109.9MQuarter to 30 Jun 2026: revenue $0, net income -$109.9MQuarter to 30 Sep 2026: revenue $570K, net income -$107.2MQuarter to 30 Sep 2026: revenue $570K, net income -$107.2M
31 Dec 2021RevenueNet incomeNet losstallest bar $110.0M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$570K-$107.2M
30 Jun 2026$0-$109.9M
31 Mar 2026$0-$105.5M
31 Dec 2025$0-$91.0M
30 Sep 2025$0-$102.2M
30 Jun 2025–-$110.0M
31 Mar 2025–-$74.7M
31 Dec 2024–-$66.5M
30 Sep 2024–-$64.5M
30 Jun 2024–-$58.5M
31 Mar 2024–-$56.9M
31 Dec 2023–-$46.1M
30 Sep 2023–-$42.4M
30 Jun 2023–-$37.9M
31 Mar 2023–-$39.4M
31 Dec 2022$0-$39.3M
30 Sep 2022$0-$43.3M
30 Jun 2022$0-$44.0M
31 Mar 2022$33.2M-$8.0M
31 Dec 2021$4.0M-$35.9M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $570K –
Revenue growthRevenue of the last 12 months compared with the 12 months before. – +8.2%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$413.6M -$353.4M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$3.23 -$3.16
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 70.4%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. – – -98.6%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. – – -47.8%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -200% -58.2%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – -$274.6M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $413.6M $369.6M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $196.2M $99.6M
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$217.4M (net cash) -$270.0M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 1.2 0.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $1.38
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 21.6
P/SPrice to sales: market cap divided by revenue of the last 12 months. over 999 8.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. over 999 6.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 34.8 2.0

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Scholar RockSRRK (this company) $5.9Blossover 999––
Kodiak SciencesKOD $6.4Bloss–––
ImmunityBioIBRX $6.4Bloss35.1+121%-608%
ImmunovantIMVT $6.6Bloss–––
Twist BioscienceTWST $7.0Bloss15.3+22%-28.3%
CG OncologyCGON $7.1Blossover 999+184%–

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

+$12.0M

bought $12.0M, sold $0

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+2.0%

309 13F filers vs 303

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

over 100%

145.5M shares held by 13F filers (30 Sep 2026) of 122.0M outstanding (6 Nov 2026); above 100%: the share count is probably stale

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

19%

23.5M shares sold short (30 Oct 2026) of 122.0M outstanding (6 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

13.6

23.5M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+5.9%

22.2M shares sold short in the report before, 23.5M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

60%

60% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 57%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

–

No data for this company

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

–

No data for this company

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$200K

4 quarters, $

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

31

31 articles in the last 7 days; its usual week has 3 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

10×

31 articles in the last 7 days; its usual week has 3.

Unusual now sharp changes in the last 90 days, compared with its own past

  • Short interest 22.7M, 1.4× a year earlier

Price $48.13 on 20 Nov 2026, +27% over 12 months (12-month range $38.02 to $60.04)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders sold a net $6.3M in the last 12 months (the 12 months before: -$65.1M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 1 published in the last 12 months (none in the 12 months before).
Revenue per quarter. Revenue $570K in the latest quarter.
Capital spending per quarter. Capital spending $101K in the latest quarter, +20% on a year earlier.
Institutional holders (13F filers). 309 13F filers reported holding it in the latest 13F quarter, +33% on a year earlier.
Lobbying spend. Lobbying spend: $200K published in the last 12 months (none in the 12 months before).

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: federal obligations, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
17 Nov 2026Sharp changeShort interest spike: short interest spike, 23.5M vs usual 16.5M (2026-10-30); 1.3x the same period a year earlier
13 Oct 2026Sharp changeShort interest spike: short interest spike, 22.7M vs usual 16.4M (2026-09-30); 1.4x the same period a year earlier
17 Feb 2026Sharp changeMany funds opening a new position: many funds opening a new position, 57 vs usual 37 (2025-12-31); 0.8x the same period a year earlier
20 Jan 2026Lobbying filingnew lobbying registration (H.A. CUMBER & COMPANY, INC.)
20 Jan 2026Sharp changeFirst lobbying registration: first lobbying registration: SCHOLAR ROCK, INC.: new lobbying registration (H.A. CUMBER & COMPANY, INC.)
3 Jun 20258-K and other filingsChanged its auditor
12 May 20258-K and other filingsChanged its auditor
28 Apr 20258-K and other filingsDirector or officer change
21 Mar 20258-K and other filingsDirector or officer change
18 Feb 2025Sharp changeMany funds opening a new position: many funds opening a new position, 70 vs usual 21 (2024-12-31); 1.7x the same period a year earlier
29 Jan 20258-K and other filingsDirector or officer change
29 Jan 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
20 Feb 2024Sharp changeMany funds opening a new position: many funds opening a new position, 41 vs usual 14 (2023-12-31); 3.7x the same period a year earlier
15 Feb 20248-K and other filingsDirector or officer change
15 Feb 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
16 Jan 2024Sharp changeShort interest spike: short interest spike, 11.3M vs usual 4.8M (2023-12-29); 4.4x the same period a year earlier
14 Nov 2023Sharp changeShort interest spike: short interest spike, 10.3M vs usual 3.9M (2023-10-31); 3.8x the same period a year earlier
1 Aug 2023Sharp changeShort interest spike: short interest spike, 5.3M vs usual 2.7M (2023-07-14); 2.0x the same period a year earlier
18 Jul 2023Sharp changeShort interest spike: short interest spike, 5.3M vs usual 2.7M (2023-06-30); 2.2x the same period a year earlier
4 Jul 2023Sharp changeShort interest spike: short interest spike, 4.4M vs usual 2.7M (2023-06-15); 1.3x the same period a year earlier
10 Apr 20238-K and other filingsDirector or officer change
10 Apr 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
9 Nov 20228-K and other filingsDirector or officer change
20 Sep 20228-K and other filingsDirector or officer change
26 Jul 20228-K and other filingsDirector or officer change
21 Jun 20228-K and other filingsDirector or officer change
21 Jun 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
17 Jun 20228-K and other filingsA major agreement ended
17 May 2022Sharp changeShort interest spike: short interest spike, 5.1M vs usual 3.4M (2022-04-29); 2.1x the same period a year earlier
17 May 2022Sharp changeQuarterly revenue change: quarterly revenue change, 33.2M vs usual 4.3M (2022-03-31); 7.1x the same period a year earlier
3 May 2022Sharp changeShort interest spike: short interest spike, 5.4M vs usual 3.4M (2022-04-14); 2.5x the same period a year earlier
12 Apr 2022Sharp changeShort interest spike: short interest spike, 5.1M vs usual 3.4M (2022-03-31); 2.7x the same period a year earlier
Insider net buying (open market)
Month from 1 Jun 2022: $5.9M published
Month from 1 Oct 2022: $1.8M published
Month from 1 Jan 2023: $445K published
Month from 1 May 2023: $203K published
Month from 1 Aug 2023: -$9K published
Month from 1 Sep 2023: -$12K published
Month from 1 Oct 2023: $30.1M published
Month from 1 Nov 2023: -$438K published
Month from 1 Dec 2023: -$1.1M published
Month from 1 Jan 2024: -$250K published
Month from 1 Feb 2024: -$411K published
Month from 1 Jun 2024: -$187K published
Month from 1 Aug 2024: -$14K published
Month from 1 Sep 2024: -$17K published
Month from 1 Oct 2024: -$44.9M published
Month from 1 Nov 2024: -$16.1M published
Month from 1 Dec 2024: -$66.6M published
Month from 1 Jan 2025: -$3.0M published
Month from 1 Feb 2025: -$4.1M published
Month from 1 Mar 2025: -$5.8M published
Month from 1 Apr 2025: -$164K published
Month from 1 May 2025: -$983K published
Month from 1 Jun 2025: -$1.7M published
Month from 1 Jul 2025: -$1.3M published
Month from 1 Aug 2025: -$68K published
Month from 1 Sep 2025: -$242K published
Month from 1 Oct 2025: $18.8M published
Month from 1 Dec 2025: -$5.0M published
Month from 1 Jan 2026: -$7.3M published
Month from 1 Feb 2026: -$1.8M published
Month from 1 Apr 2026: -$3.1M published
Month from 1 Jul 2026: -$923K published
Month from 1 Oct 2026: $12.0M published
H-1B/E-3 applications certified
Quarter from 1 Oct 2026: 1 published
Revenue per quarter
Quarter ended 31 Dec 2021: $4.0M, +18% on a year earlier; public on 8 Mar 2022
Quarter ended 31 Mar 2022: $33.2M, +605% on a year earlier; public on 17 May 2022
Quarter ended 30 Jun 2022: $0, -100% on a year earlier; public on 9 Aug 2022
Quarter ended 30 Sep 2022: $0, -100% on a year earlier; public on 15 Nov 2022
Quarter ended 31 Dec 2022: $0, -100% on a year earlier; public on 8 Mar 2023
Quarter ended 30 Sep 2025: $0; public on 11 Nov 2026
Quarter ended 31 Dec 2025: $0; public on 4 Mar 2026
Quarter ended 31 Mar 2026: $0; public on 8 May 2026
Quarter ended 30 Jun 2026: $0; public on 7 Aug 2026
Quarter ended 30 Sep 2026: $570K; public on 11 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $542K; public on 8 Mar 2022
Quarter ended 31 Mar 2022: $443K, -81% on a year earlier; public on 17 May 2022
Quarter ended 30 Jun 2022: $477K, -51% on a year earlier; public on 9 Aug 2022
Quarter ended 30 Sep 2022: $27K, -98% on a year earlier; public on 15 Nov 2022
Quarter ended 31 Dec 2022: $117K, -78% on a year earlier; public on 8 Mar 2023
Quarter ended 31 Mar 2023: $30K, -93% on a year earlier; public on 10 May 2023
Quarter ended 30 Jun 2023: $41K, -91% on a year earlier; public on 10 Aug 2023
Quarter ended 31 Mar 2024: $23K, -23% on a year earlier; public on 8 May 2024
Quarter ended 30 Jun 2024: $22K, -46% on a year earlier; public on 9 Aug 2024
Quarter ended 30 Sep 2024: $31K; public on 13 Nov 2024
Quarter ended 31 Dec 2024: $22K; public on 28 Feb 2025
Quarter ended 31 Mar 2025: $271K, +1078% on a year earlier; public on 15 May 2025
Quarter ended 30 Jun 2025: $215K, +877% on a year earlier; public on 7 Aug 2025
Quarter ended 30 Sep 2025: $84K, +171% on a year earlier; public on 15 Nov 2025
Quarter ended 31 Dec 2025: $32K, +45% on a year earlier; public on 4 Mar 2026
Quarter ended 31 Mar 2026: $68K, -75% on a year earlier; public on 8 May 2026
Quarter ended 30 Sep 2026: $101K, +20% on a year earlier; public on 11 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 82; public on 14 Feb 2022
31 Mar 2022 report: 88; public on 16 May 2022
30 Jun 2022 report: 81; public on 15 Aug 2022
30 Sep 2022 report: 78; public on 14 Nov 2022
31 Dec 2022 report: 78; public on 14 Feb 2023
31 Mar 2023 report: 82; public on 15 May 2023
30 Jun 2023 report: 80; public on 14 Aug 2023
30 Sep 2023 report: 85; public on 14 Nov 2023
31 Dec 2023 report: 124; public on 14 Feb 2024
31 Mar 2024 report: 152; public on 15 May 2024
30 Jun 2024 report: 157; public on 14 Aug 2024
30 Sep 2024 report: 156; public on 14 Nov 2024
31 Dec 2024 report: 220; public on 14 Feb 2025
31 Mar 2025 report: 224; public on 15 May 2025
30 Jun 2025 report: 225; public on 14 Aug 2025
30 Sep 2025 report: 233; public on 14 Nov 2025
31 Dec 2025 report: 265; public on 17 Feb 2026
31 Mar 2026 report: 268; public on 15 May 2026
30 Jun 2026 report: 303; public on 14 Aug 2026
30 Sep 2026 report: 309; public on 16 Nov 2026
Lobbying spend
Quarter from 1 Jan 2026: $200K published

What is unusual now

  • Made public in the last 90 days: it had 22.7M shares sold short in the 30 Sep 2026 report, 1.4× the same report last year; it also had 23.5M shares sold short in the 30 Oct 2026 report, 1.3× the same report last year.
  • Short interest spike: had 22.7M shares sold short in the 30 Sep 2026 report, 1.4× the same report last year Public on 10 Oct 2026.
  • Insider net buying (open market): Insiders sold a net $6.3M in the last 12 months (the 12 months before: -$65.1M).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 1 published in the last 12 months (none in the 12 months before).

Latest records

The names and amounts behind the totals, newest first

Last 90 days: no sales; 1 purchase, $12.0M. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
27 Oct 2026Srinivas AkkarajuDirectorBuy289,470$41.45$12.0MForm 4
6 Jul 2026Joshua ReedDirectorSellplanned in advance (10b5-1)3,053$53.74$164KForm 4
6 Jul 2026Katie PengDirectorSellplanned in advance (10b5-1)5,446$53.87$293KForm 4
6 Jul 2026Michael GilmanDirectorSellplanned in advance (10b5-1)2,544$53.87$137KForm 4
6 Jul 2026Kristina BurowDirectorSellplanned in advance (10b5-1)3,053$53.74$164KForm 4
6 Jul 2026Jeffrey S. FlierDirectorSellplanned in advance (10b5-1)3,053$53.88$164KForm 4
20 Apr 2026Vikas SinhaChief Financial OfficerSell10,410$49.57$516KForm 4
20 Apr 2026Akshay VaishnawPresident of R&DSell12,246$49.57$607KForm 4

309 institutions reported shares at the end of Q3 2026, 100% of the shares outstanding; 47 opened a position, 37 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
FMR LLC (Fidelity)18.2M14.9%$879.8M+212K+1.2%
BlackRock, Inc.9.6M7.83%$461.9M+64K+0.7%
Siren, L.L.C.9.4M7.68%$453.0M-200K-2.1%
Wellington Management Group LLP8.7M7.14%$420.8M+2.0M+29%
Samsara Biocapital, LLC6.9M5.65%$333.3MNo change
Orbis Allan Gray Ltd6.1M4.98%$293.6M+142K+2.4%
T. Rowe Price Associates Inc5.9M4.81%-929K-14%
Vanguard Capital Management LLC4.8M3.94%$232.2M+37K+0.8%
Massachusetts Financial Services Co4.7M3.82%$224.9M+2.0M+79%
State Street Corp4.4M3.59%$211.4M-353K-7.5%

Company events

All 40 company events

In 12 months: 1 major agreement. Results releases and routine reports are left out.

FiledWhat happenedSource
10 Nov 2026Agreed to sell Rare Pediatric Disease Priority Review Voucher to BioNTech US Inc. for $205 million in cash8-K
3 Jun 2025Changed its auditor8-K
12 May 2025Changed its auditor8-K
28 Apr 2025Director or officer change8-K
21 Mar 2025Director or officer change8-K
29 Jan 2025Director or officer change8-K
10 Oct 2024Signed a major agreement8-K
22 May 2024Signed a major agreement8-K

Reported lobbying spend: $200K in Q4 2025. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
15 Dec 2025NewH.A. Cumber & Company, Inc.for Scholar Rock, Inc.Biologics License ApplicationMEDFiling

The 5 newest of 184 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

17 Feb 2026confirmed

Confirmed across sources Institutional holdings and Lobbying

Scholar Rock (SRRK): registered for federal lobbying for the first time in our data (H.A. Cumber & Company, Inc.), while it saw 57 13F filers open a new position in the quarter ended 31 Dec 2025, 19% below the same quarter last year. Two unrelated kinds of activity within 28 days.

  • Lobbying: First lobbying registration, became public on 20 Jan 2026
  • Institutional holdings: Many funds opening a new position, became public on 17 Feb 2026
2023-12-31: 412024-03-31: 382024-06-30: 282024-09-30: 212024-12-31: 702025-03-31: 342025-06-30: 362025-09-30: 392025-12-31: 57
The quarter ended 31 Dec 2025 against the 8 quarters before it. this quarterearliernormal: 37
See the evidence (2 changes)

Lobbying: First lobbying registration became public on 20 Jan 2026

Scholar Rock registered for federal lobbying for the first time in our data (H.A. Cumber & Company, Inc.).

Source coverage starts
4 Apr 2008
Earlier events of other kinds
0

"First" means first in our data: it fires only when the source's history began at least 365 days earlier.

Institutional holdings: Many funds opening a new position became public on 17 Feb 2026

Scholar Rock saw 57 13F filers open a new position in the quarter ended 31 Dec 2025, 19% below the same quarter last year.

This period
57 (the quarter ended 31 Dec 2025)
Normal quarter (median of 8 earlier)
37
Typical spread (median absolute deviation)
3.5
How far from its usual level
+3.9
Same quarter last year
70
History used
2,741 days
2023-12-31: 412024-03-31: 382024-06-30: 282024-09-30: 212024-12-31: 702025-03-31: 342025-06-30: 362025-09-30: 392025-12-31: 57
the quarter ended 31 Dec 20258 earlier quartersnormal: 37

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

17 May 2022confirmed

Confirmed across sources Filings + Financials and Short interest and volume

Scholar Rock (SRRK): had 5.4M shares sold short in the 14 Apr 2022 report, 2.5× the same report last year, while it reported revenue of $33.2M for the quarter ended 31 Mar 2022, 7.1× the same quarter last year. Two unrelated kinds of activity within 14 days.

  • Short interest and volume: Short interest spike, became public on 27 Apr 2022
  • Financials: Quarterly revenue change, became public on 17 May 2022
  • Short interest and volume: Short interest spike, became public on 11 May 2022
2021-03-31: 1.9M2021-04-15: 2.2M2021-04-30: 2.4M2021-05-14: 2.4M2021-05-28: 2.5M2021-06-15: 2.6M2021-06-30: 3.4M2021-07-15: 3.5M2021-07-30: 3.7M2021-08-13: 3.7M2021-08-31: 3.5M2021-09-15: 3.4M2021-09-30: 3.1M2021-10-15: 3.2M2021-10-29: 3.4M2021-11-15: 3.8M2021-11-30: 3.8M2021-12-15: 3.7M2022-01-14: 3.5M2022-01-31: 3.2M2022-02-15: 3.4M2022-02-28: 3.8M2022-03-15: 4.3M2022-03-31: 5.1M2022-04-14: 5.4M
The 14 Apr 2022 report against the 24 reports before it. this reportearliernormal: 3.4M
See the evidence (3 changes)

Short interest and volume: Short interest spike became public on 27 Apr 2022

Scholar Rock had 5.4M shares sold short in the 14 Apr 2022 report, 2.5× the same report last year.

This period
5.4M (the 14 Apr 2022 report)
Normal report (median of 24 earlier)
3.4M
Typical spread (median absolute deviation)
296K
How far from its usual level
+4.6
Same report last year
2.2M
History used
1,399 days
2021-03-31: 1.9M2021-04-15: 2.2M2021-04-30: 2.4M2021-05-14: 2.4M2021-05-28: 2.5M2021-06-15: 2.6M2021-06-30: 3.4M2021-07-15: 3.5M2021-07-30: 3.7M2021-08-13: 3.7M2021-08-31: 3.5M2021-09-15: 3.4M2021-09-30: 3.1M2021-10-15: 3.2M2021-10-29: 3.4M2021-11-15: 3.8M2021-11-30: 3.8M2021-12-15: 3.7M2022-01-14: 3.5M2022-01-31: 3.2M2022-02-15: 3.4M2022-02-28: 3.8M2022-03-15: 4.3M2022-03-31: 5.1M2022-04-14: 5.4M
the 14 Apr 2022 report24 earlier reportsnormal: 3.4M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Financials: Quarterly revenue change became public on 17 May 2022

Scholar Rock reported revenue of $33.2M for the quarter ended 31 Mar 2022, 7.1× the same quarter last year.

This period
$33.2M (the quarter ended 31 Mar 2022)
Normal quarter (median of 8 earlier)
$4.3M
Typical spread (median absolute deviation)
$565K
How far from its usual level
+28.9
Same quarter last year
$4.7M
History used
1,735 days
2020-03-31: $5.0M2020-06-30: $3.9M2020-09-30: $3.0M2020-12-31: $3.4M2021-03-31: $4.7M2021-06-30: $4.6M2021-09-30: $5.5M2021-12-31: $4.0M2022-03-31: $33.2M
the quarter ended 31 Mar 20228 earlier quartersnormal: $4.3M

Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

Check it at the source: SEC EDGAR quarterly reports.

Short interest and volume: Short interest spike became public on 11 May 2022

Scholar Rock had 5.1M shares sold short in the 29 Apr 2022 report, 2.1× the same report last year.

This period
5.1M (the 29 Apr 2022 report)
Normal report (median of 24 earlier)
3.4M
Typical spread (median absolute deviation)
296K
How far from its usual level
+3.7
Same report last year
2.4M
History used
1,414 days
2021-04-15: 2.2M2021-04-30: 2.4M2021-05-14: 2.4M2021-05-28: 2.5M2021-06-15: 2.6M2021-06-30: 3.4M2021-07-15: 3.5M2021-07-30: 3.7M2021-08-13: 3.7M2021-08-31: 3.5M2021-09-15: 3.4M2021-09-30: 3.1M2021-10-15: 3.2M2021-10-29: 3.4M2021-11-15: 3.8M2021-11-30: 3.8M2021-12-15: 3.7M2022-01-14: 3.5M2022-01-31: 3.2M2022-02-15: 3.4M2022-02-28: 3.8M2022-03-15: 4.3M2022-03-31: 5.1M2022-04-14: 5.4M2022-04-29: 5.1M
the 29 Apr 2022 report24 earlier reportsnormal: 3.4M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 11 Nov 2026Short interest and volume change

    had 23.5M shares sold short in the 30 Oct 2026 report, 1.3× the same report last year.

    Same report last year: 17.9M; its normal report is 16.5M.

    See the evidence
    This period
    23.5M (the 30 Oct 2026 report)
    Normal report (median of 24 earlier)
    16.5M
    Typical spread (median absolute deviation)
    1.2M
    How far from its usual level
    +3.8
    Same report last year
    17.9M
    History used
    3,059 days
    2025-10-31: 17.9M2025-11-14: 17.2M2025-11-28: 15.9M2025-12-15: 16.6M2025-12-31: 14.7M2026-01-15: 15.7M2026-01-30: 15.5M2026-02-13: 15.6M2026-02-27: 14.5M2026-03-13: 14.3M2026-03-31: 15.7M2026-04-15: 14.8M2026-04-30: 14.9M2026-05-15: 15.7M2026-05-29: 16.4M2026-06-15: 16.7M2026-06-30: 18.4M2026-07-15: 17.6M2026-07-31: 17.7M2026-08-14: 18.2M2026-08-31: 18.0M2026-09-15: 19.4M2026-09-30: 22.7M2026-10-15: 22.2M2026-10-30: 23.5M
    the 30 Oct 2026 report24 earlier reportsnormal: 16.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  2. 27 Oct 2026Insiders record

    AKKARAJU SRINIVAS (director) bought 289,470 shares of SRRK ($12.0M)

  3. 10 Oct 2026Short interest and volume change

    had 22.7M shares sold short in the 30 Sep 2026 report, 1.4× the same report last year.

    Same report last year: 16.4M; its normal report is 16.4M.

    See the evidence
    This period
    22.7M (the 30 Sep 2026 report)
    Normal report (median of 24 earlier)
    16.4M
    Typical spread (median absolute deviation)
    1.0M
    How far from its usual level
    +3.8
    Same report last year
    16.4M
    History used
    3,029 days
    2025-09-30: 16.4M2025-10-15: 16.9M2025-10-31: 17.9M2025-11-14: 17.2M2025-11-28: 15.9M2025-12-15: 16.6M2025-12-31: 14.7M2026-01-15: 15.7M2026-01-30: 15.5M2026-02-13: 15.6M2026-02-27: 14.5M2026-03-13: 14.3M2026-03-31: 15.7M2026-04-15: 14.8M2026-04-30: 14.9M2026-05-15: 15.7M2026-05-29: 16.4M2026-06-15: 16.7M2026-06-30: 18.4M2026-07-15: 17.6M2026-07-31: 17.7M2026-08-14: 18.2M2026-08-31: 18.0M2026-09-15: 19.4M2026-09-30: 22.7M
    the 30 Sep 2026 report24 earlier reportsnormal: 16.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  4. 17 Feb 2026several at once

    registered for federal lobbying for the first time in our data (H.A. Cumber & Company, Inc.), while it saw 57 13F filers open a new position in the quarter ended 31 Dec 2025, 19% below the same quarter last year. Two unrelated kinds of activity within 28 days.

    See the evidence (2 changes)

    Lobbying: First lobbying registration became public on 20 Jan 2026

    Scholar Rock registered for federal lobbying for the first time in our data (H.A. Cumber & Company, Inc.).

    Source coverage starts
    4 Apr 2008
    Earlier events of other kinds
    0

    "First" means first in our data: it fires only when the source's history began at least 365 days earlier.

    Institutional holdings: Many funds opening a new position became public on 17 Feb 2026

    Scholar Rock saw 57 13F filers open a new position in the quarter ended 31 Dec 2025, 19% below the same quarter last year.

    This period
    57 (the quarter ended 31 Dec 2025)
    Normal quarter (median of 8 earlier)
    37
    Typical spread (median absolute deviation)
    3.5
    How far from its usual level
    +3.9
    Same quarter last year
    70
    History used
    2,741 days
    2023-12-31: 412024-03-31: 382024-06-30: 282024-09-30: 212024-12-31: 702025-03-31: 342025-06-30: 362025-09-30: 392025-12-31: 57
    the quarter ended 31 Dec 20258 earlier quartersnormal: 37

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  5. 17 Feb 2026Institutional holdings change

    saw 57 13F filers open a new position in the quarter ended 31 Dec 2025, 19% below the same quarter last year.

    Same quarter last year: 70; its normal quarter is 37.

    See the evidence
    This period
    57 (the quarter ended 31 Dec 2025)
    Normal quarter (median of 8 earlier)
    37
    Typical spread (median absolute deviation)
    3.5
    How far from its usual level
    +3.9
    Same quarter last year
    70
    History used
    2,741 days
    2023-12-31: 412024-03-31: 382024-06-30: 282024-09-30: 212024-12-31: 702025-03-31: 342025-06-30: 362025-09-30: 392025-12-31: 57
    the quarter ended 31 Dec 20258 earlier quartersnormal: 37

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  6. 20 Jan 2026Lobbying change

    registered for federal lobbying for the first time in our data (H.A. Cumber & Company, Inc.).

    See the evidence (1 source record)
    Source coverage starts
    4 Apr 2008
    Earlier events of other kinds
    0

    "First" means first in our data: it fires only when the source's history began at least 365 days earlier.

  7. 20 Jan 2026Lobbying record

    SCHOLAR ROCK, INC.: new lobbying registration (H.A. CUMBER & COMPANY, INC.) (dated 15 Dec 2025)

  8. 17 Dec 2025Insiders record

    AKKARAJU SRINIVAS (director) bought 29,599 shares of SRRK ($1.2M) (dated 16 Dec 2025)

  9. 8 Oct 2025Insiders record

    AKKARAJU SRINIVAS (director) bought 500,439 shares of SRRK ($18.8M) (dated 7 Oct 2025)

  10. 3 Jun 2025Filings record

    Changed its auditor

  11. 12 May 2025Filings record

    Changed its auditor

  12. 28 Apr 2025Filings record

    Director or officer change

  13. 21 Mar 2025Filings record

    Director or officer change

  14. 14 Feb 2025Institutional holdings change

    saw 70 13F filers open a new position in the quarter ended 31 Dec 2024, 1.7× the same quarter last year.

    Same quarter last year: 41; its normal quarter is 21.

    See the evidence
    This period
    70 (the quarter ended 31 Dec 2024)
    Normal quarter (median of 8 earlier)
    21
    Typical spread (median absolute deviation)
    7.5
    How far from its usual level
    +4.4
    Same quarter last year
    41
    History used
    2,376 days
    2022-12-31: 112023-03-31: 132023-06-30: 212023-09-30: 152023-12-31: 412024-03-31: 382024-06-30: 282024-09-30: 212024-12-31: 70
    the quarter ended 31 Dec 20248 earlier quartersnormal: 21

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  15. 29 Jan 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  16. 29 Jan 2025Filings record

    Director or officer change

  17. 15 Feb 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  18. 15 Feb 2024Filings record

    Director or officer change

  19. 14 Feb 2024Institutional holdings change

    saw 41 13F filers open a new position in the quarter ended 31 Dec 2023, 3.7× the same quarter last year.

    Same quarter last year: 11; its normal quarter is 14.

    See the evidence
    This period
    41 (the quarter ended 31 Dec 2023)
    Normal quarter (median of 8 earlier)
    14
    Typical spread (median absolute deviation)
    3
    How far from its usual level
    +6.1
    Same quarter last year
    11
    History used
    2,010 days
    2021-12-31: 72022-03-31: 162022-06-30: 232022-09-30: 112022-12-31: 112023-03-31: 132023-06-30: 212023-09-30: 152023-12-31: 41
    the quarter ended 31 Dec 20238 earlier quartersnormal: 14

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  20. 11 Jan 2024Short interest and volume change

    had 11.3M shares sold short in the 29 Dec 2023 report, 4.4× the same report last year.

    Same report last year: 2.6M; its normal report is 4.8M.

    See the evidence
    This period
    11.3M (the 29 Dec 2023 report)
    Normal report (median of 24 earlier)
    4.8M
    Typical spread (median absolute deviation)
    1.2M
    How far from its usual level
    +3.7
    Same report last year
    2.6M
    History used
    2,023 days
    2022-12-30: 2.6M2023-01-13: 2.7M2023-01-31: 2.8M2023-02-15: 2.9M2023-02-28: 3.0M2023-03-15: 3.4M2023-03-31: 3.5M2023-04-14: 3.8M2023-04-28: 4.1M2023-05-15: 3.9M2023-05-31: 4.1M2023-06-15: 4.4M2023-06-30: 5.3M2023-07-14: 5.3M2023-07-31: 5.4M2023-08-15: 5.6M2023-08-31: 5.4M2023-09-15: 5.7M2023-09-29: 5.9M2023-10-13: 6.1M2023-10-31: 10.3M2023-11-15: 10.3M2023-11-30: 10.1M2023-12-15: 10.2M2023-12-29: 11.3M
    the 29 Dec 2023 report24 earlier reportsnormal: 4.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  21. 10 Nov 2023Short interest and volume change

    had 10.3M shares sold short in the 31 Oct 2023 report, 3.8× the same report last year.

    Same report last year: 2.7M; its normal report is 3.9M.

    See the evidence
    This period
    10.3M (the 31 Oct 2023 report)
    Normal report (median of 24 earlier)
    3.9M
    Typical spread (median absolute deviation)
    1.2M
    How far from its usual level
    +3.6
    Same report last year
    2.7M
    History used
    1,964 days
    2022-10-31: 2.7M2022-11-15: 2.6M2022-11-30: 2.5M2022-12-15: 2.5M2022-12-30: 2.6M2023-01-13: 2.7M2023-01-31: 2.8M2023-02-15: 2.9M2023-02-28: 3.0M2023-03-15: 3.4M2023-03-31: 3.5M2023-04-14: 3.8M2023-04-28: 4.1M2023-05-15: 3.9M2023-05-31: 4.1M2023-06-15: 4.4M2023-06-30: 5.3M2023-07-14: 5.3M2023-07-31: 5.4M2023-08-15: 5.6M2023-08-31: 5.4M2023-09-15: 5.7M2023-09-29: 5.9M2023-10-13: 6.1M2023-10-31: 10.3M
    the 31 Oct 2023 report24 earlier reportsnormal: 3.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  22. 19 Oct 2023Insiders record

    AKKARAJU SRINIVAS (director) bought 2,189,781 shares of SRRK [same transaction as an earlier filing] (dated 18 Oct 2023)

  23. 19 Oct 2023Insiders record

    Samsara BioCapital GP, LLC (ten percent owner) and 1 other(s) bought 2,189,781 shares of SRRK ($15.0M) (dated 18 Oct 2023)

  24. 17 Oct 2023Insiders record

    Wittouck Amaury (ten percent owner) and 7 other(s) bought 2,199,931 shares of SRRK ($15.1M) (dated 16 Oct 2023)

  25. 26 Jul 2023Short interest and volume change

    had 5.3M shares sold short in the 14 Jul 2023 report, 2.0× the same report last year.

    Same report last year: 2.6M; its normal report is 2.7M.

    See the evidence
    This period
    5.3M (the 14 Jul 2023 report)
    Normal report (median of 24 earlier)
    2.7M
    Typical spread (median absolute deviation)
    387K
    How far from its usual level
    +4.5
    Same report last year
    2.6M
    History used
    1,855 days
    2022-07-15: 2.6M2022-07-29: 2.3M2022-08-15: 2.2M2022-08-31: 1.8M2022-09-15: 1.7M2022-09-30: 2.4M2022-10-14: 2.3M2022-10-31: 2.7M2022-11-15: 2.6M2022-11-30: 2.5M2022-12-15: 2.5M2022-12-30: 2.6M2023-01-13: 2.7M2023-01-31: 2.8M2023-02-15: 2.9M2023-02-28: 3.0M2023-03-15: 3.4M2023-03-31: 3.5M2023-04-14: 3.8M2023-04-28: 4.1M2023-05-15: 3.9M2023-05-31: 4.1M2023-06-15: 4.4M2023-06-30: 5.3M2023-07-14: 5.3M
    the 14 Jul 2023 report24 earlier reportsnormal: 2.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  26. 13 Jul 2023Short interest and volume change

    had 5.3M shares sold short in the 30 Jun 2023 report, 2.2× the same report last year.

    Same report last year: 2.4M; its normal report is 2.7M.

    See the evidence
    This period
    5.3M (the 30 Jun 2023 report)
    Normal report (median of 24 earlier)
    2.7M
    Typical spread (median absolute deviation)
    332K
    How far from its usual level
    +5.3
    Same report last year
    2.4M
    History used
    1,841 days
    2022-06-30: 2.4M2022-07-15: 2.6M2022-07-29: 2.3M2022-08-15: 2.2M2022-08-31: 1.8M2022-09-15: 1.7M2022-09-30: 2.4M2022-10-14: 2.3M2022-10-31: 2.7M2022-11-15: 2.6M2022-11-30: 2.5M2022-12-15: 2.5M2022-12-30: 2.6M2023-01-13: 2.7M2023-01-31: 2.8M2023-02-15: 2.9M2023-02-28: 3.0M2023-03-15: 3.4M2023-03-31: 3.5M2023-04-14: 3.8M2023-04-28: 4.1M2023-05-15: 3.9M2023-05-31: 4.1M2023-06-15: 4.4M2023-06-30: 5.3M
    the 30 Jun 2023 report24 earlier reportsnormal: 2.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  27. 28 Jun 2023Short interest and volume change

    had 4.4M shares sold short in the 15 Jun 2023 report, 1.3× the same report last year.

    Same report last year: 3.4M; its normal report is 2.7M.

    See the evidence
    This period
    4.4M (the 15 Jun 2023 report)
    Normal report (median of 24 earlier)
    2.7M
    Typical spread (median absolute deviation)
    332K
    How far from its usual level
    +3.5
    Same report last year
    3.4M
    History used
    1,826 days
    2022-06-15: 3.4M2022-06-30: 2.4M2022-07-15: 2.6M2022-07-29: 2.3M2022-08-15: 2.2M2022-08-31: 1.8M2022-09-15: 1.7M2022-09-30: 2.4M2022-10-14: 2.3M2022-10-31: 2.7M2022-11-15: 2.6M2022-11-30: 2.5M2022-12-15: 2.5M2022-12-30: 2.6M2023-01-13: 2.7M2023-01-31: 2.8M2023-02-15: 2.9M2023-02-28: 3.0M2023-03-15: 3.4M2023-03-31: 3.5M2023-04-14: 3.8M2023-04-28: 4.1M2023-05-15: 3.9M2023-05-31: 4.1M2023-06-15: 4.4M
    the 15 Jun 2023 report24 earlier reportsnormal: 2.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  28. 3 May 2023Insiders record

    Artal International Management S.A. (ten percent owner) and 7 other(s) bought 31,557 shares of SRRK ($202,912) (dated 2 May 2023)

  29. 10 Apr 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  30. 10 Apr 2023Filings record

    Director or officer change

  31. 10 Jan 2023Insiders record

    Artal Group S.A. (ten percent owner) and 7 other(s) bought 48,774 shares of SRRK ($455,061) (dated 9 Jan 2023)

  32. 9 Nov 2022Filings record

    Director or officer change

  33. 28 Oct 2022Insiders record

    Stichting Administratiekantoor Westend (ten percent owner) and 7 other(s) bought 130,265 shares of SRRK ($1.0M) (dated 27 Oct 2022)

  34. 8 Oct 2022Insiders record

    Invus Public Equities Advisors, LLC (ten percent owner) and 7 other(s) bought 99,971 shares of SRRK ($759,556) (dated 7 Oct 2022)

  35. 20 Sep 2022Filings record

    Director or officer change

  36. 26 Jul 2022Filings record

    Director or officer change

  37. 25 Jun 2022Insiders record

    Nashat Amir (director) bought 1,197,992 shares of SRRK ($5.9M) (dated 24 Jun 2022)

  38. 21 Jun 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  39. 21 Jun 2022Filings record

    Director or officer change

  40. 17 Jun 2022Filings record

    A major agreement ended

Showing the newest 40 of 71 entries; narrow the window or the kind of data to see older ones.

Not listed: 217 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001727196
Ticker
SRRK
Domain
scholarrock.com
Hq location
MA|CAMBRIDGE|02142 (1 unverified)
Lobbying client
scholar rock
Name
Scholar Rock Foreign Holdings, Inc, Scholar Rock Germany GmbH, Scholar Rock Holding Corporation, Scholar Rock, Inc and 5 more
  • DOL H-1B labor condition applications and PERM certifications5 data points17 Aug 2026 to 17 Aug 2026
  • Federal lobbying disclosures (LDA)1 record, 9 data points15 Dec 2025 to 30 Sep 2026
  • SEC Form 13F institutional holdings306 data points30 Jun 2018 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)144 records8 Jan 2018 to 10 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)560 data points31 Dec 2016 to 6 Nov 2026
  • SEC Form 4 insider transactions115 records, 244 data points31 May 2018 to 27 Oct 2026
  • FINRA short interest (twice monthly)603 data points15 Jun 2018 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026